Karl Halteman is Director, Treasury & Risk Management for WIL Research Company, Inc. WIL is a privately held global Contract Research Organization that provides product safety toxicological research, bioanalytical, and formulation services to the pharmaceutical, biotechnology, chemical, agrochemical, and food products industries as well as manufacturing support for clinical trials. In his role, he oversees global cash & working capital management, debt compliance, insurance, supply chain management and internal controls for the company. Previously, he held external and internal audit positions at Deloitte, Cendant Corporation and Avis Budget Group.
Mr. Halteman earned a bachelor of science in Accounting and Management Information Systems from Syracuse University and an executive MBA in Finance and Leadership from the Stern School of Business at New York University.
Mr. Halteman is an active member in the New Jersey Society of CPAs. He received the Distinguished Service Award from the organization for his work as chairperson of the Student Programs & Scholarships Committee and as a trustee of the Society’s scholarship fund. He also served on the Board of Trustees of the Society and is currently a member of the Strategic Planning Committee.
Follow him on Twitter @TravelingCPA
|  |